The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of KRAS/NRAS mutations in phase 3 study 20050181 of panitumumab (pmab) plus FOLFIRI versus FOLFIRI for second-line treatment (tx) of metastatic colorectal cancer (mCRC).
Marc Peeters
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Research Funding - Amgen
Kelly S. Oliner
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Timothy Jay Price
Consultant or Advisory Role - Amgen (U)
Honoraria - Amgen
Andres Cervantes
No relevant relationships to disclose
Alberto F. Sobrero
Consultant or Advisory Role - Amgen; Bayer; Merck; Roche; Sanofi
Honoraria - Amgen; Bayer; Celgene; Roche; Sanofi
Michel Ducreux
Consultant or Advisory Role - Roche
Honoraria - Amgen; Bayer; Biocompatibles; Merck; Pfizer; Roche
Research Funding - Pfizer; Roche
Yevhen Hotko
Disclosure not yet available
Thierry Andre
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Emily Chan
Consultant or Advisory Role - Amgen
Research Funding - Amgen
Florian Lordick
Consultant or Advisory Role - Amgen; GANYMED Pharmaceuticals
Research Funding - Fresenius Biotech; GlaxoSmithKline
Cornelis J. A. Punt
No relevant relationships to disclose
Andrew Strickland
No relevant relationships to disclose
Gregory Wilson
Honoraria - Amgen
Other Remuneration - Amgen
Tudor-Eliade Ciuleanu
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Laslo Roman
No relevant relationships to disclose
Eric Van Cutsem
Research Funding - Amgen
Ying Tian
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Andre Scott Jung
Employment or Leadership Position - Amgen
Roger Sidhu
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Scott D. Patterson
Employment or Leadership Position - Amgen
Stock Ownership - Amgen